Top Tweets for #TeamFormycon
MS Pharma becomes Partner for the Commercialization of FYB202 in the MENA Region
Read more in our Corporate News: https://t.co/xuDfY0Ke26
#TeamFormycon #FYB #Biosimilars #Uste #MENA
Formycon applies for admission to the Prime Standard of the Frankfurt Stock Exchange
Further information on the uplisting has been published in our Corporate News today: https://t.co/2ILdPRapRI
#TeamFormycon #Biosimilars #Uplisting #Prime #Standard #Frankfurt #Prospectus
Vielen Dank Formycon AG, Patrick Stevens und Team für eure großzügige IT-Spende über 105 Laptops.
#labdoo #TeamFormycon #ITDonation #EducationForAll #EmpoweringYouth #münchen #martinsried #danke #thankyou #münchen #munich #Formycon
Industry-specific requirements for a digital portfolio and project management platform –
Formycon showcases innovative solutions at cPlace Pharma Circle.
#TeamFormycon #project #management #cplace #vision #exchange
Impressive uptake for FYB201/Cimerli® in the U.S. with more than 100,000 doses in sales within the first year and 25% market share in the U.S. ranibizumab market.
Learn more in today's press release
https://t.co/72lYeJxuA5
#TeamFormycon #Biosimilars #Ophthalmology #AMD #Coherus
With the H1 figures published on August 30, 2023, we look back on an extremely successful first half of 2023.
Read more in our Corporate News published today:
https://t.co/cOOZ7YKhtU
#TeamFormycon #Biosimilars #Development #HalfYearReport
We are delighted that the #FDA has accepted the biologics license application for our Eylea® biosimilar candidate #FYB203 and set a target action date of June 2024. Read more in our Corporate News released today: https://t.co/jXqXeVS8nq
#TeamFormycon #Biosimilars #Ophthalmology
H1 Earnings Call on August 30, 2023 at 15:00 (CEST)
For details on the conference call, please refer to our Corporate News published today:
https://t.co/8RSoNlX7QP
#TeamFormycon #Biosimilars #Biotech #H1 #IR
We are looking forward to a good exchange and interesting talks at the 10th Investors Day Hamburg 2023 next week. For Formycon, Enno Spillner (CFO) will make his way to the "Hansestadt".
#HIT #Hamburg #Montegaconnect #IR #Investorrelations #TeamFormycon #Biosimilars #Biotech
After three virtual AGMs due to the pandemic, our Annual General Meeting 2023 was once again held in presence in the well-filled Europasaal of the Haus der bayerischen Wirtschaft in Munich.
For further details go to: https://t.co/k2dGOsJemP
#AGM #IR #TeamFormycon
Great sport by our #TeamFormycon sport groups #RUNibizumab and #RanibizuNET - at the #B2Run Munich as well as at the Business Beach Cup in Krailling. Congratulations to all participants! We are really proud of you! #Teamwork counts - in sports, at work, all over!
Formycon has submitted the biologics license application for its aflibercept #biosimilar candidate #FYB203 to the #FDA
Please find our press release here:
https://t.co/jGQV68f3RB
#TeamFormycon #Ophthalmology #nAMD #biotech #Eylea
We are very pleased to have been nominated in the "Company of the Year" category of the European Mediscience Award 2023 and congratulate Novo Nordisk and all other winners at this year's award event.
https://t.co/b7qYul9Gp0
#TeamFormycon #Biosimilars #MediscienceAward
Formycon today published its key figures for the first quarter of 2023.
For further information see our Corporate News:
https://t.co/R9o3dWJO2S
#TeamFormycon #Biosimilars #Reporting #Q1 #Figures
2022 was an exciting and successful year for Formycon. In the annual report just published, we look back at the major events and share information on the current status of our #development projects:
https://t.co/dcSxPIG7tA
#TeamFormycon #Biosimilars #Covid19 #AnnualReport
𝐀𝐟𝐥𝐢𝐛𝐞𝐫𝐜𝐞𝐩𝐭 𝐁𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫 𝐂𝐚𝐧𝐝𝐢𝐝𝐚𝐭𝐞 𝐅𝐘𝐁𝟐𝟎𝟑:
Primary efficacy endpoint for submission to the #FDA achieved in global phase III study
https://t.co/0bGKH0YgEX
#TeamFormycon #FYB203 #Biosimilar #Ophthalmology #AMD #PhaseIII
Have a peaceful Christmas season and a fantastic new year!
#TeamFormycon #MerryChristmas #HappyNewYear #newyear2023
What a wonderful conclusion to an eventful year! After two years of abstinence, it was really nice to celebrate the end of the year in presence with almost the entire #TeamFormycon. Many thanks to Andrea for the perfect organization. And a wonderful Advent season to all of you!
Great job #Formycon Running Team #RUNibizumab! Our colleagues competed in various disciplines at the Munich Marathon on October 9, 2022. One highlight: The #Marathon Team Relay! Great team spirit, great commitment, great performance #WinnerOfTheHearts!
#TeamFormycon #Laufgruppe
𝗘𝗨 𝗮𝗽𝗽𝗿𝗼𝘃𝗮𝗹 𝗳𝗼𝗿 𝗙𝗬𝗕𝟮𝟬𝟭
We are very excited about the EU approval of FYB201, the third major milestone within a few weeks. Special thanks to the entire #TeamFormycon for their great commitment and outstanding work!
https://t.co/yk7KnEK9ew
Last Seen Hashtags on Sotwe
chuukese
Seen from United States
robloxcondo drones
Seen from Singapore
monkeyappwinsFull
Seen from United Kingdom
cuck
Seen from Singapore
momson filter:videos
Seen from United States
คนแก่เย็ดเด็ก
Seen from Thailand
momsonn
Seen from Pakistan
ديوت_بدوي
Seen from Switzerland
สาวสอง
Seen from Thailand
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
113.9M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.6M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.7M followers
Taylor Swift
@taylorswift13
83.7M followers
Lady Gaga
@ladygaga
75.1M followers
Virat Kohli
@imvkohli
72.9M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
65.9M followers
Bill Gates
@billgates
64.9M followers
Selena Gomez
@selenagomez
62.8M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers